Blood test could offer less invasive way to guide breast cancer treatment
NCT ID NCT06706570
Summary
This study aims to improve the diagnosis of metastatic breast cancer by comparing different methods of testing for a specific gene mutation called PIK3CA. Researchers will test 100 patients using both a standard tissue biopsy and a less invasive blood test (liquid biopsy) to see if the results match. The goal is to see if a simple blood draw can reliably guide treatment decisions, potentially avoiding more invasive procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
European Institute of Oncology
RECRUITINGMilan, MI, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.